mAb Industry in China: Biosimilars vs Innovative Biologics is creating huge potential for biosimilars, prompting innovators to shift their focus to .. Read more target more emerging markets which remain untapped for many companies. In this presentation, Joe will be sharing with you his vision of the biosimilars market with a focus on China. He will also discuss key considerations for mAb and biologics therapeutic development, providing a broad overview of challenges and opportunities presenting in the market.
Dr Joe X ZhouCEO at Genor Biopharma, Walvax Bio Group
Sarah (Xuyu) WangHead of Segment Marketing, Biosimilars and Bioconjugations at Sartorius Stedim...
- [ Users who have shown interest for this Event ]
- Share your Experience
BIOPHARMA ASIA MAGAZINESouth Korea 50 Total Events / 18 Upcoming Events
More Events From The Organizer
- Establishing Early Development..21 Oct 2020Online